Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Cordonnier

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
Critical Care Medicine|November 16, 2004
Sepsis associated with immunosuppressive medications: an evidence-based reviewJuan C Gea-Banacloche, Steven M Opal, James Jorgensen, et al.
Leukemia|April 8, 2025
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)Livio Pagano, Georg Maschmeyer, Frederic Lamoth, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2017
ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipientsSimone Cesaro, Tina Dalianis, Christine Hanssen Rinaldo, et al.
The Journal of Infection|October 29, 2017
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelinesMalgorzata Mikulska, Diana Averbuch, Frederic Tissot, et al.
Medical Mycology|July 9, 2010
Primary in vitro culture of porcine tracheal epithelial cells in an air-liquid interface as a model to study airway epithelium and Aspergillus fumigatus interactionsKhaled Khoufache, Odile Cabaret, Cécile Farrugia, et al.
International Journal of Antimicrobial Agents|December 29, 2007
Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME StudyCatherine Cordonnier, Mohamad Mohty, Catherine Faucher, et al.
Mycoses|July 28, 2015
High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?Dea Garcia-Hermoso, Alexandre Alanio, Odile Cabaret, et al.
Haematologica|November 13, 2010
Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control studyCaroline Even, Sylvie Bastuji-Garin, Yosr Hicheri, et al.
Journal of the American Academy of Dermatology|October 16, 2013
Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemiaLivia Delgado, Stephane Giraudier, Nicolas Ortonne, et al.
BMC Microbiology|June 20, 2008
Phagocytosis of Aspergillus fumigatus conidia by primary nasal epithelial cells in vitroFrançoise Botterel, Karine Gross, Oumaïma Ibrahim-Granet, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
Critical Care Medicine|November 16, 2004
Sepsis associated with immunosuppressive medications: an evidence-based reviewJuan C Gea-Banacloche, Steven M Opal, James Jorgensen, et al.
Leukemia|April 8, 2025
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)Livio Pagano, Georg Maschmeyer, Frederic Lamoth, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2017
ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipientsSimone Cesaro, Tina Dalianis, Christine Hanssen Rinaldo, et al.
The Journal of Infection|October 29, 2017
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelinesMalgorzata Mikulska, Diana Averbuch, Frederic Tissot, et al.
Medical Mycology|July 9, 2010
Primary in vitro culture of porcine tracheal epithelial cells in an air-liquid interface as a model to study airway epithelium and Aspergillus fumigatus interactionsKhaled Khoufache, Odile Cabaret, Cécile Farrugia, et al.
International Journal of Antimicrobial Agents|December 29, 2007
Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME StudyCatherine Cordonnier, Mohamad Mohty, Catherine Faucher, et al.
Mycoses|July 28, 2015
High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?Dea Garcia-Hermoso, Alexandre Alanio, Odile Cabaret, et al.
Haematologica|November 13, 2010
Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control studyCaroline Even, Sylvie Bastuji-Garin, Yosr Hicheri, et al.
Journal of the American Academy of Dermatology|October 16, 2013
Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemiaLivia Delgado, Stephane Giraudier, Nicolas Ortonne, et al.
BMC Microbiology|June 20, 2008
Phagocytosis of Aspergillus fumigatus conidia by primary nasal epithelial cells in vitroFrançoise Botterel, Karine Gross, Oumaïma Ibrahim-Granet, et al.
Pageof 15